BridgeBio Pharma, Inc. — SC 13D/A Filings
18 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 18 SC 13D/A documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | — | 0000905148-24-002952 | Nov 6, 2024 | — |
| SC 13D/A | SC 13D/A | 0001140361-24-041327 | Sep 17, 2024 | — |
| SC 13D/A | SC 13D/A | 0001140361-24-037981 | Aug 20, 2024 | — |
| SC 13D/A | SC 13D/A | 0001140361-23-054445 | Nov 22, 2023 | — |
| SC 13D/A | SC 13D/A | 0001140361-23-035291 | Jul 20, 2023 | — |
| SC 13D/A | SC 13D/A | 0001140361-21-005265 | Feb 17, 2021 | — |
| SC 13D/A | SC 13D/A #1 | 0001193125-21-017733 | Jan 26, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-017128 | Jan 26, 2021 | — |
| SC 13D/A | SC 13D/A | 0001140361-20-022590 | Oct 6, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-264026 | Oct 5, 2020 | — |
| SC 13D/A | SC 13D/A | 0001140361-20-012844 | Jun 1, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-267356 | Oct 15, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-216833 | Aug 8, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-190741 | Jul 9, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-159860 | May 30, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-18-347912 | Dec 13, 2018 | — |
| SC 13D/A | SC 13D/A | 0001193125-18-346386 | Dec 11, 2018 | — |
| SC 13D/A | SC 13D/A | 0001193125-18-344046 | Dec 7, 2018 | — |